ImportRefusal LogoImportRefusal

Shandong Lukang Shelile Pharmaceutical Co., Ltd.

⚠️ Moderate Risk

FEI: 3001040579 • Jining, Shandong • CHINA

FEI

FEI Number

3001040579

📍

Location

Jining, Shandong

🇨🇳

Country

CHINA
🏢

Address

Hualu Road, Zoucheng Industrial Park 50, , Jining, Shandong, China

Moderate Risk

FDA Import Risk Assessment

41.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

7
Total Refusals
4
Unique Violations
3/16/2015
Latest Refusal
11/6/2012
Earliest Refusal

Score Breakdown

Violation Severity
71.3×40%
Refusal Volume
33.5×30%
Recency
0.0×20%
Frequency
29.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

725×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
3/16/2015
56LXS99NON-CERT VET ANTIBIOTIC, N.E.C.
72NEW VET DR
Detroit District Office (DET-DO)
3/16/2015
56LXS99NON-CERT VET ANTIBIOTIC, N.E.C.
72NEW VET DR
Detroit District Office (DET-DO)
3/16/2015
56LXS99NON-CERT VET ANTIBIOTIC, N.E.C.
72NEW VET DR
Detroit District Office (DET-DO)
2/19/2015
56LXS99NON-CERT VET ANTIBIOTIC, N.E.C.
118NOT LISTED
Detroit District Office (DET-DO)
5/8/2013
56LCY72TYLOSIN TARTRATE (NON-CERTIFIABLE)
72NEW VET DR
Los Angeles District Office (LOS-DO)
5/8/2013
56LCY72TYLOSIN TARTRATE (NON-CERTIFIABLE)
72NEW VET DR
Los Angeles District Office (LOS-DO)
11/6/2012
56LXS72TYLOSIN TARTRATE (NON-CERTIFIABLE)
472NO ENGLISH
75UNAPPROVED
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Shandong Lukang Shelile Pharmaceutical Co., Ltd.'s FDA import refusal history?

Shandong Lukang Shelile Pharmaceutical Co., Ltd. (FEI: 3001040579) has 7 FDA import refusal record(s) in our database, spanning from 11/6/2012 to 3/16/2015.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Shandong Lukang Shelile Pharmaceutical Co., Ltd.'s FEI number is 3001040579.

What types of violations has Shandong Lukang Shelile Pharmaceutical Co., Ltd. received?

Shandong Lukang Shelile Pharmaceutical Co., Ltd. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Shandong Lukang Shelile Pharmaceutical Co., Ltd. come from?

All FDA import refusal data for Shandong Lukang Shelile Pharmaceutical Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.